Yahoo Finance • 10 days ago
Comprehensive SWOT analysis highlighting Gilead Sciences Inc's strategic positioning in the biopharmaceutical industry. Insightful examination of Gilead Sciences Inc's financial performance, including revenue growth and R&D investments. Fo... Full story
Yahoo Finance • 15 days ago
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has... Full story
Yahoo Finance • a month ago
In this article, we will take a detailed look at the 12 Best Depressed Stocks To Buy in 2024. For a quick overview of the 5 such stocks, read our article5 Best Depressed Stocks To Buy in 2024. JPMorgan Chief Jamie Dimon, in his latest let... Full story
Yahoo Finance • 2 months ago
In this article, we discuss 15 best NASDAQ dividend stocks to buy. You can skip our detailed analysis of NASDAQ stocks and the performance of dividend stocks over the years, and go directly to read 5 Best NASDAQ Dividend Stocks To Buy. Th... Full story
Yahoo Finance • 2 months ago
In this article, we discuss 13 best pharma dividend stocks to buy in 2024. You can skip our detailed analysis of the pharma sector and its performance, and go directly to read 5 Best Pharma Dividend Stocks To Buy in 2024. Within the healt... Full story
Yahoo Finance • 3 months ago
– 19 Organizations Will Receive a Total of $12.6 Million in Grant Funding Through Gilead’s Setting the P.A.C.E. Initiative – FOSTER CITY, Calif., February 27, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced it... Full story
Yahoo Finance • 3 months ago
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In Th... Full story
Yahoo Finance • 3 months ago
In this article, we will be taking a look at the 15 most expensive medical treatments/procedures in the world. If you are not interested in reading about the landscape of expensive medical treatments, head straight to the 5 Most Expensive... Full story
Yahoo Finance • 3 months ago
NORTHAMPTON, MA / ACCESSWIRE / February 13, 2024 / Long-time liver specialist Carrie Frenette says she won't ever forget the people she treated for hepatitis C (HCV) before 2013 - the year that the Food and Drug Administration (FDA) approv... Full story
Yahoo Finance • 3 months ago
CymaBay stock skyrocketed Monday after Gilead Sciences announced it will buy it for $4.3 billion. CBAY stock surged almost 25%. Continue reading... Full story
Yahoo Finance • 3 months ago
In this article, we discuss the top 11 CRISPR stocks to invest in. If you want to skip our discussion of the gene editing industry, head directly to Top 5 CRISPR Stocks To Invest In. Genome editing refers to a set of technologies enabling... Full story
Yahoo Finance • 3 months ago
In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want to skip our detailed analysis of the pharmaceutical drugs market, you can go directly to 5 Most Valuable Drug Companies in 2024. The Global P... Full story
Yahoo Finance • 3 months ago
– Company Also Ranked in Top 5 of Pharmaceuticals and Biotech Industry – FOSTER CITY, Calif., February 09, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company has been named one of America’s Most JUST C... Full story
Yahoo Finance • 3 months ago
Total Revenue: Full year 2023 revenue decreased by 1% to $27.1 billion, with a 4% decline in Q4 2023 to $7.1 billion year-over-year. Earnings Per Share (EPS): Diluted EPS for Q4 2023 was $1.14, down from $1.30 in Q4 2022, while full year E... Full story
Yahoo Finance • 3 months ago
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript February 6, 2024 Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good... Full story
Yahoo Finance • 4 months ago
FOSTER CITY, Calif., February 01, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Ted Love, MD, has been appointed to the company’s Board of Directors. Dr. Love is currently chair of the Board of Directors... Full story
Yahoo Finance • 4 months ago
(Adds details from FDA's letters in paragraphs 7-8) Jan 22 (Reuters) - The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made b... Full story
Yahoo Finance • 4 months ago
Jan 22 (Reuters) - The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made by Gilead Sciences, Johnson & Johnson, Novartis and ot... Full story
Yahoo Finance • 4 months ago
FOSTER CITY, Calif., January 22, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Phase 3 EVOKE-01 study did not meet its primary endpoint of overall survival (OS) in previously treated metastatic non-sm... Full story
Yahoo Finance • 4 months ago
By Deena Beasley Jan 22 (Reuters) - Gilead Sciences on Monday said a late-stage trial of its antibody-drug conjugate Trodelvy failed to show that it significantly improved survival for previously treated patients with advanced non-small c... Full story
Home
Money Search
Trending Sports
Gallery
Shop
Blog
Examples
Data & Glossary
Elements of Bball
Harden Maze
About
